blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4251175

EP4251175 - ADIPOGENIC CELL COMPOSITIONS AND METHODS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  01.09.2023
Database last updated on 16.09.2024
FormerThe international publication has been made
Status updated on  04.06.2022
Most recent event   Tooltip26.01.2024Change: Validation statespublished on 28.02.2024  [2024/09]
26.01.2024Change - extension statespublished on 28.02.2024  [2024/09]
Applicant(s)For all designated states
Flagship Pioneering, Inc.
55 Cambridge Parkway
8th Floor, Suite 800E
Cambridge, MA 02142 / US
[2023/40]
Inventor(s)01 / DE BOER, Alexandra, Sophie
Cambridge, MA 02142 / US
02 / NGO, Le P.
Cambridge, MA 02142 / US
03 / KAHVEJIAN, Avak
Cambridge, MA 02142 / US
04 / LEWANDOWSKI, Jordan
Cambridge, MA 02142 / US
 [2023/40]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[2023/40]
Application number, filing date21899119.824.11.2021
[2023/40]
WO2021US60831
Priority number, dateUS202063118226P25.11.2020         Original published format: US 202063118226 P
US202063118237P25.11.2020         Original published format: US 202063118237 P
US202063118235P25.11.2020         Original published format: US 202063118235 P
US202063118232P25.11.2020         Original published format: US 202063118232 P
[2023/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022115609
Date:02.06.2022
Language:EN
[2022/22]
Type: A1 Application with search report 
No.:EP4251175
Date:04.10.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 02.06.2022 takes the place of the publication of the European patent application.
[2023/40]
Search report(s)International search report - published on:US02.06.2022
ClassificationIPC:A61K35/12, A61K35/28, A61K35/35, A61L27/00, A61P17/00, A61P43/00
[2023/40]
CPC:
A61L27/3804 (EP,KR); A61K35/28 (EP,KR,US); A61K35/35 (EP,KR,US);
A61K38/1816 (EP,KR,US); A61K38/44 (EP,KR); A61K45/06 (EP,KR);
A61L27/3834 (EP,KR); A61L27/54 (EP,KR); A61P17/00 (EP,KR);
A61P43/00 (EP,KR,US); C12N5/0653 (EP,KR,US); C12N5/0665 (US);
C12N9/0071 (EP,KR); C12Y114/16001 (EP,US); A61L2300/64 (EP,KR);
C12N2501/145 (EP,KR); C12N2501/22 (EP,KR,US); C12N2501/2303 (EP,KR,US);
C12N2501/26 (EP,KR,US); C12N2501/33 (EP,KR,US); C12N2501/39 (EP,KR);
C12N2506/11 (EP,KR); C12N2506/1369 (US); C12N2506/1384 (EP,KR);
C12N2510/00 (EP,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/40]
TitleGerman:ADIPOGENE ZELLZUSAMMENSETZUNGEN UND VERFAHREN[2023/40]
English:ADIPOGENIC CELL COMPOSITIONS AND METHODS[2023/40]
French:COMPOSITIONS DE CELLULES ADIPOGÉNIQUES ET PROCÉDÉS[2023/40]
Entry into regional phase12.06.2023National basic fee paid 
12.06.2023Search fee paid 
12.06.2023Designation fee(s) paid 
12.06.2023Examination fee paid 
Examination procedure12.06.2023Examination requested  [2023/40]
15.01.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.11.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2008095750  (GIMBLE JEFFREY M [US], et al);
 [Y]US2011038923  (WEISINGER GARY [IL], et al);
 [X]US2011268708  (LIN CHING SHWUN [US], et al);
 [A]US2012315254  (HAMED SAHER [IL]);
 [A]US9062288  (VESEY GRAHAM [AU]);
 [Y]US2016187317  (SUGI SHIGEKI [SG], et al);
 [XY]US2017258851  (BRAVO EDUARDO [ES], et al);
 [A]WO2019173435  (EPIBONE INC [US], et al);
 [Y]US2020016400  (FISHER PAUL [US], et al);
 [A]WO2020064793  (BONE THERAPEUTICS SA [BE]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.